FundedIQ
Biotechnology

MatriSys Bioscience: Funding, Investors & Team (Oct 2026)

MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients.

matrisysbio.com LinkedIn La Jolla, United States 1-10 employees
Biopharma Biotechnology Health Care Medical Pharmaceutical
Total raised
$3.0M
Rounds
1
Latest
Undisclosed round
Mar 2021

MatriSys Bioscience has raised $3.0M across 1 funding round on record, the most recent an undisclosed round of $3.0M announced in Mar 2021.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

MatriSys Bioscience Company Profile and Key Stats

Total funding raised
$3.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$3.0M in Mar 2021
Employees
1-10
reported band
Headquarters
La Jolla, United States

Latest funding round on record: Mar 2021.

MatriSys Bioscience Funding Rounds

Date
Round
Amount
Undisclosed round
$3.0M

MatriSys Bioscience Founders and Leadership Team

Name
Role
Contact
Philippe Calais
CEO
—

No contact details are on record for this team yet.

MatriSys Bioscience Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

MatriSys Bioscience's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like MatriSys Bioscience in Biotechnology and La Jolla

Companies Similar to MatriSys Bioscience

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

MatriSys Bioscience Funding FAQs

What does MatriSys Bioscience do?

MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients.

How much funding has MatriSys Bioscience raised?

MatriSys Bioscience has raised $3.0M across 1 round on record. The most recent is an undisclosed round of $3.0M announced in Mar 2021.

When did MatriSys Bioscience last raise funding?

MatriSys Bioscience's most recent funding round on record is an undisclosed round of $3.0M, announced in Mar 2021.

Who is the CEO of MatriSys Bioscience?

Philippe Calais is listed as CEO at MatriSys Bioscience.

Where is MatriSys Bioscience headquartered?

MatriSys Bioscience is based in La Jolla, California, United States.

How many employees does MatriSys Bioscience have?

MatriSys Bioscience is in the 1-10 employee band.

How does MatriSys Bioscience's funding compare to other Biotechnology startups?

MatriSys Bioscience's latest round of $3.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's MatriSys Bioscience Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MatriSys Bioscience is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.